Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progression

Abstract Background Accumulating evidence indicates importance of RNA regulation in cancer. This includes events such as splicing, translation, and regulation of noncoding RNAs, functions which are governed by RNA binding proteins (RBPs). Aims To find which RBPs could be relevant for prostate cancer...

Full description

Bibliographic Details
Main Authors: Erika Aikio, Sonja Koivukoski, Elina Kallio, Nithin Sadeesh, Einari A. Niskanen, Leena Latonen
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.1886
_version_ 1797650746989084672
author Erika Aikio
Sonja Koivukoski
Elina Kallio
Nithin Sadeesh
Einari A. Niskanen
Leena Latonen
author_facet Erika Aikio
Sonja Koivukoski
Elina Kallio
Nithin Sadeesh
Einari A. Niskanen
Leena Latonen
author_sort Erika Aikio
collection DOAJ
description Abstract Background Accumulating evidence indicates importance of RNA regulation in cancer. This includes events such as splicing, translation, and regulation of noncoding RNAs, functions which are governed by RNA binding proteins (RBPs). Aims To find which RBPs could be relevant for prostate cancer, we performed systematic screening of RBP expression in clinical prostate cancer. Methods and Results We interrogated four proteome‐wide proteomics datasets including tumor samples of primary, castration resistant, and metastatic prostate cancer. We found that, while the majority of RBPs are expressed but not significantly altered during prostate cancer development and progression, expression of several RBPs increases in advanced disease. Interestingly, most of the differentially expressed RBPs are not targets of differential posttranscriptional phosphorylation during disease progression. The RBPs undergoing expression changes have functions in, especially, poly(A)‐RNA binding, nucleocytoplasmic transport, and cellular stress responses, suggesting that these may play a role in formation of castration resistance. Pathway analyzes indicate that increased ribosome production and chromatin‐related functions of RBPs are also linked to castration resistant and metastatic prostate cancers. We selected a group of differentially expressed RBPs and studied their role in cultured prostate cancer cells. With siRNA screens, several of these were indicated in survival (DDX6, EIF4A3, PABPN1), growth (e.g., EIF5A, HNRNPH2, LRRC47, and NVL), and migration (e.g., NOL3 and SLTM) of prostate cancer cells. Our analyzes further show that RRP9, a U3 small nucleolar protein essential for ribosome formation, undergoes changes at protein level during metastasis in prostate cancer. Conclusion In this work, we recognized significant molecular alterations in RBP profiles during development and evolution of prostate cancer. Our study further indicates several functionally significant RBPs warranting further investigation for their functions and possible targetability in prostate cancer.
first_indexed 2024-03-11T16:05:54Z
format Article
id doaj.art-352d6ac8ad3d4738847cd30c187c7ad2
institution Directory Open Access Journal
issn 2573-8348
language English
last_indexed 2024-03-11T16:05:54Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj.art-352d6ac8ad3d4738847cd30c187c7ad22023-10-25T03:24:42ZengWileyCancer Reports2573-83482023-10-01610n/an/a10.1002/cnr2.1886Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progressionErika Aikio0Sonja Koivukoski1Elina Kallio2Nithin Sadeesh3Einari A. Niskanen4Leena Latonen5Institute of Biomedicine University of Eastern Finland Kuopio FinlandInstitute of Biomedicine University of Eastern Finland Kuopio FinlandInstitute of Biomedicine University of Eastern Finland Kuopio FinlandInstitute of Biomedicine University of Eastern Finland Kuopio FinlandInstitute of Biomedicine University of Eastern Finland Kuopio FinlandInstitute of Biomedicine University of Eastern Finland Kuopio FinlandAbstract Background Accumulating evidence indicates importance of RNA regulation in cancer. This includes events such as splicing, translation, and regulation of noncoding RNAs, functions which are governed by RNA binding proteins (RBPs). Aims To find which RBPs could be relevant for prostate cancer, we performed systematic screening of RBP expression in clinical prostate cancer. Methods and Results We interrogated four proteome‐wide proteomics datasets including tumor samples of primary, castration resistant, and metastatic prostate cancer. We found that, while the majority of RBPs are expressed but not significantly altered during prostate cancer development and progression, expression of several RBPs increases in advanced disease. Interestingly, most of the differentially expressed RBPs are not targets of differential posttranscriptional phosphorylation during disease progression. The RBPs undergoing expression changes have functions in, especially, poly(A)‐RNA binding, nucleocytoplasmic transport, and cellular stress responses, suggesting that these may play a role in formation of castration resistance. Pathway analyzes indicate that increased ribosome production and chromatin‐related functions of RBPs are also linked to castration resistant and metastatic prostate cancers. We selected a group of differentially expressed RBPs and studied their role in cultured prostate cancer cells. With siRNA screens, several of these were indicated in survival (DDX6, EIF4A3, PABPN1), growth (e.g., EIF5A, HNRNPH2, LRRC47, and NVL), and migration (e.g., NOL3 and SLTM) of prostate cancer cells. Our analyzes further show that RRP9, a U3 small nucleolar protein essential for ribosome formation, undergoes changes at protein level during metastasis in prostate cancer. Conclusion In this work, we recognized significant molecular alterations in RBP profiles during development and evolution of prostate cancer. Our study further indicates several functionally significant RBPs warranting further investigation for their functions and possible targetability in prostate cancer.https://doi.org/10.1002/cnr2.1886castration resistancemetastasisprostate cancerRNA binding proteins
spellingShingle Erika Aikio
Sonja Koivukoski
Elina Kallio
Nithin Sadeesh
Einari A. Niskanen
Leena Latonen
Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progression
Cancer Reports
castration resistance
metastasis
prostate cancer
RNA binding proteins
title Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progression
title_full Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progression
title_fullStr Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progression
title_full_unstemmed Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progression
title_short Complementary analysis of proteome‐wide proteomics reveals changes in RNA binding protein‐profiles during prostate cancer progression
title_sort complementary analysis of proteome wide proteomics reveals changes in rna binding protein profiles during prostate cancer progression
topic castration resistance
metastasis
prostate cancer
RNA binding proteins
url https://doi.org/10.1002/cnr2.1886
work_keys_str_mv AT erikaaikio complementaryanalysisofproteomewideproteomicsrevealschangesinrnabindingproteinprofilesduringprostatecancerprogression
AT sonjakoivukoski complementaryanalysisofproteomewideproteomicsrevealschangesinrnabindingproteinprofilesduringprostatecancerprogression
AT elinakallio complementaryanalysisofproteomewideproteomicsrevealschangesinrnabindingproteinprofilesduringprostatecancerprogression
AT nithinsadeesh complementaryanalysisofproteomewideproteomicsrevealschangesinrnabindingproteinprofilesduringprostatecancerprogression
AT einarianiskanen complementaryanalysisofproteomewideproteomicsrevealschangesinrnabindingproteinprofilesduringprostatecancerprogression
AT leenalatonen complementaryanalysisofproteomewideproteomicsrevealschangesinrnabindingproteinprofilesduringprostatecancerprogression